Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

IMPC Term

decreased T cell number 1 | 31
increased CD4-positive, alpha ... 1 | 15
increased leukocyte cell numbe... 1 | 37

Disease

osteosarcoma 5 | 7,933
ovarian cancer 5 | 8,492
psoriasis 5 | 6,685
Breast cancer 4 | 3,099
Cancer 4 | 2,346
Rheumatoid Arthritis 4 | 1,171
cutaneous lupus erythematosus 4 | 1,056
interstitial cystitis 4 | 2,299
lung cancer 4 | 4,473
Adult T-Cell Lymphoma/Leukemia 3 | 30
Multiple Sclerosis 3 | 498
medulloblastoma, large-cell 3 | 6,234
primary Sjogren syndrome 3 | 789
Alopecia areata 2 | 37
Asthma 2 | 349
Berylliosis 2 | 28
Celiac disease 2 | 112
Hypersensitivity reaction type II disease 2 | 235
Juvenile rheumatoid arthritis 2 | 105
Lymphoma, T-Cell, Cutaneous 2 | 21
Mycosis fungoides 2 | 30
Primary cutaneous T-cell lymphoma 2 | 29
Sezary's disease 2 | 11
atypical teratoid / rhabdoid tumor 2 | 4,369
colon cancer 2 | 1,475
glioblastoma 2 | 5,572
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
invasive ductal carcinoma 2 | 2,950
pancreatic cancer 2 | 2,300
pediatric high grade glioma 2 | 2,712
primary pancreatic ductal adenocarcinoma 2 | 1,271
primitive neuroectodermal tumor 2 | 3,031
sarcoidosis 2 | 368
Addison's disease 1 | 29
Adenocarcinoma of lung (disorder) 1 | 48
Agammaglobulinemia 1 | 24
Alcoholic Intoxication, Chronic 1 | 41
Autistic Disorder 1 | 320
Autoimmune Diseases 1 | 33
Autoimmune thyroiditis 1 | 24
Autosomal recessive early-onset Parkinson disease 15 1 | 5
Balkan Nephropathy 1 | 6
Biliary Cirrhosis, Secondary 1 | 5
Brain disease 1 | 84
COPD 1 | 116
Chloracne 1 | 32
Colitis 1 | 46
Common variable immunodeficiency 1 | 98
Common variable immunodeficiency 2 1 | 4
Cornelia de Lange syndrome 1 | 21
Dementia 1 | 129
Diabetes Mellitus, Insulin-Dependent 1 | 77
Diarrhea 1 | 155
Drug psychosis 1 | 7
Exanthem 1 | 39
Gaucher's disease 1 | 25
Graft-vs-Host Disease 1 | 5
Graves Disease 1 | 17
Graves' disease 1 | 25
HIV Infections 1 | 100
Hepatitis B 1 | 103
Hepatolenticular Degeneration 1 | 24
Human immunodeficiency virus infectious disease 1 | 129
Idiopathic Membranous Glomerulonephritis 1 | 18
Lewy Body Disease 1 | 19
Liver disease 1 | 219
Marginal Zone B-Cell Lymphoma 1 | 1
Melanoma 1 | 261
Meningitis 1 | 46
Metastatic malignant melanoma 1 | 9
Multiple system atrophy 1 | 27
Nerve Degeneration 1 | 73
Neurodegenerative Disorders 1 | 37
Neurodegenerative disease 1 | 383
Olivopontocerebellar atrophy 1 | 9
Optic atrophy 1 | 43
Oral Submucous Fibrosis 1 | 18
Osteoarthritis, Knee 1 | 1
PARKINSON DISEASE, LATE-ONSET 1 | 20
Pantothenate kinase-associated neurodegeneration 1 | 15
Parkinson Disease 1 | 105
Parkinsonian Disorders 1 | 23
Peripheral T-cell lymphoma 1 | 24
Pick's disease 1 | 14
Psychoses, Substance-Induced 1 | 17
REM sleep behavior disorder 1 | 16
SARCOIDOSIS, SUSCEPTIBILITY TO, 2 1 | 1
Sarcoidosis 2 1 | 1
Sickle Cell Anemia 1 | 54
Sporotrichosis 1 | 5
Thyroiditis 1 | 25
Thyrotoxicosis 1 | 38
Toxic encephalopathy 1 | 131
Toxic shock syndrome 1 | 28
Type 1 diabetes mellitus 1 | 104
Uveitis 1 | 103
Vaccinia 1 | 37
Vitiligo 1 | 71
systemic lupus erythematosus 1 | 172

Tissue

Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444
Liver and Pancreas 6 | 18,136

Target Family

Non-IDG 7 | 11,969

Grant Application

5R01AI054912-02 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
CD276 antigen CD276 Tbio Non-IDG -3.01052 733.9 392
Cytotoxic T-lymphocyte protein 4 CTLA4 Tclin Non-IDG -3.53985 3564.0 656
Butyrophilin-like protein 2 BTNL2 Tbio Non-IDG -2.55048 348.3 64
Alpha-synuclein SNCA Tchem Non-IDG -3.61306 3997.3 1484
Inducible T-cell costimulator ICOS Tbio Non-IDG -1.52153 31.7 495
T-cell-specific surface glycoprotein CD28 CD28 Tchem Non-IDG -1.96341 107.1 1174
V-set domain-containing T-cell activation inhibitor 1 VTCN1 Tbio Non-IDG -2.15340 156.3 396